Health Ministry includes people with HIV in coverage for CAR-T therapies

Until now, these patients, even if they had an undetectable viral load, were excluded from the access protocols for these therapies due to the lack of clinical data to support their safety and efficacy in this group. Read

The Ministry of Health has extended the coverage of CAR-T therapies to people with HIV with an undetectable viral load, who have so far been denied access due to the lack of clinical data to support their safety and efficacy because they have always been excluded from clinical trials.Health has updated the drug protocols and funding criteria to allow this group access to CAR-T therapies, thus eliminating the discriminatory barriers still on them…

The State Coordinator for HIV and AIDS (CESIDA) has welcomed the recent decision of the Ministry of Health to lift the restrictions that prevented people with human immunodeficiency virus (HIV) from accessing CAR-T cancer therapies, thus ending "unfair exclusion".

The Ministry of Health has extended the coverage of CAR-T therapies to people with HIV with an undetectable viral load, who have so far been denied access due to the lack of clinical data to support their safety and efficacy because they have always been excluded from clinical trials.Health has updated the drug protocols and funding criteria to allow this group access to CAR-T therapies, thus eliminating the discriminatory barriers still on them…

CAR-T (Chimeric Antigen Recipe T-Cell) is a type of cell and gene therapy in which the patient becomes his or her own donor. It consists of modifying the patient's T lymphocytes so that they have the ability to attack tumor cells. Through apheresis, a technique that allows the separation of blood components, T lymphocytes are obtained and genetically reprogrammed so that, when they are transfused back to the patient, they can specifically recogn…